New Results

Etifoxine inhibits NLRP3 inflammasome activity in human and murine myeloid cells

Jordan M. Osmond, John B. Williams, Paul M. Matthews, David R. Owen, Craig S. Moore
doi: https://doi.org/10.1101/2023.09.19.558428

Article Information

doi 
https://doi.org/10.1101/2023.09.19.558428
History 
  • September 21, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Jordan M. Osmond1,
  2. John B. Williams1,
  3. Paul M. Matthews2,3,
  4. David R. Owen2 and
  5. Craig S. Moore1,*
  1. 1Faculty of Medicine, Memorial University of Newfoundland, Newfoundland, Canada
  2. 2Division of Brain Sciences, Imperial College London, UK
  3. 3UK Dementia Research Institute Centre at Imperial College London, UK
  1. ↵*Corresponding Author:
    Craig S. Moore, PhD Health Sciences Centre, Room HSC5339, 300 Prince Philip Drive, St. John’s, NL, Canada, A1B 3V6 Tel: 709 864 4955, craig.moore{at}mun.ca
Back to top
Posted September 21, 2023.
Download PDF

Supplementary Material

Email
Etifoxine inhibits NLRP3 inflammasome activity in human and murine myeloid cells
Jordan M. Osmond, John B. Williams, Paul M. Matthews, David R. Owen, Craig S. Moore
bioRxiv 2023.09.19.558428; doi: https://doi.org/10.1101/2023.09.19.558428
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area